Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Orum Therapeutics
Biotech
BMS snags another ADC with modest $100M Orum deal
Another day, another ADC deal. This time it’s BMS snapping up Orum Therapeutics’ phase 1 blood cancer med for $100 million upfront.
Annalee Armstrong
Nov 6, 2023 7:00am
Orum adds $54M to 2019 series B to move ADCs into the clinic
Jun 23, 2021 9:41am
Orum bags $30M to build out its platform to drug the 'undruggable'
Jul 17, 2019 12:00am
Korean biotech Orum raises $8M for cell-penetrating antibody tech
Jun 14, 2017 8:00am
Cracking an 'undruggable' cancer mutation
May 11, 2017 12:44pm